Bafna Pharmaceuticals Limited (BAFNAPH) — Board Meeting | 11 August 2026

11 August 2026 · NSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved Q1 FY27 results and set AGM date

🔄 What Changed

Q1 revenue ₹2,658.32 lakhs, profit ₹7.51 lakhs, EPS ₹0.03

🔮 What's Next

31st AGM on September 11, 2026; record date September 4, 2026

Bafna Pharmaceuticals announced the outcome of its August 11, 2026 board meeting, approving unaudited Q1 FY27 financial results, setting the 31st AGM for September 11, 2026 with record date September 4, and closing books from September 5-11. The unaudited Q1 results show revenue of ₹2,658.32 lakhs, profit of ₹7.51 lakhs, and total comprehensive income of ₹13.59 lakhs, with EPS of [amount context mismatch]. The board also addressed GST liabilities of INR 235.47 lakhs under appeal.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BAFNAPH ✨ Ask AI About This

About Bafna Pharmaceuticals Limited (BAFNAPH)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹875.99 Cr

View full BAFNAPH stock details →

📡 Get AI alerts when BAFNAPH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BAFNAPH — Free

💡 Ask AI about this filing

"How does Q1 revenue compare to previous year?""What is the expected impact of GST appeal outcome?""When will full FY27 results be released?"

Ask AI Free →

📊 More BAFNAPH filings

Announcement — 26 September 2026Bafna Pharmaceuticals announced that its trading window will close on October 1, 2026, and remain sh...
🟡 Voting Results — 11 September 2026Bafna Pharmaceuticals held its 31st AGM on September 11, 2026, where shareholders approved the adopt...
🟡 Board Meeting — 11 September 2026Bafna Pharmaceuticals held its 31st AGM on September 11, 2026 via video conference, adopting audited...
🔴 Annual Report — 19 August 2026Bafna Pharmaceuticals Limited announced its 31st Annual General Meeting (AGM) to be held on Septembe...
🟡 Board Meeting — 13 August 2026Bafna Pharmaceuticals announced its 31st Annual General Meeting will be held on September 11, 2026, ...

See all BAFNAPH filings →

🔥 Also filed on 11 August 2026

ULTRACEMCOUltraTech Cement LimitedAnnouncement SUDEEPPHRMSudeep Pharma LimitedFinancial Results SUTLEJTEXSutlej Textiles and Industries LimitedFinancial Results RBZJEWELRBZ Jewellers LimitedFinancial Results TATVATatva Chintan Pharma Chem LimitedCorporate Action AETHERAether Industries LimitedCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BAFNAPH files new disclosures

Track BAFNAPH filings, board meetings, and corporate actions. Free email alerts at 5 PM.